CA-VELODYNE-LIDAR,-INC.
28.8.2020 14:02:10 CEST | Business Wire | Press release
Velodyne Lidar, Inc. today announced it has joined the Intelligent Transportation Society of America (ITS America) to promote the benefits of autonomous vehicles and intelligent transportation infrastructure. Velodyne is the first lidar technology company to become part of this influential group. ITS America members are at the forefront of driving progress in autonomous vehicles and smart city solutions to help save lives, improve mobility and promote sustainability.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200828005057/en/
Velodyne’s lidar sensors can be used in a variety of Intelligent Transportation Systems to measure and monitor conditions in areas such as pedestrian safety, vehicle traffic and parking space management, and more. They can collect reliable, detailed traffic data about road users, including vehicles, pedestrians and bicyclists, while preserving anonymity. Velodyne’s lidar sensors do not identify individuals’ facial characteristics, a growing requirement for civic applications. In addition to transportation systems, Velodyne’s lidar sensors have a strong presence in autonomous vehicles and advanced driver assistance systems (ADAS).
Velodyne has a long-standing commitment to fostering understanding of the safety and mobility benefits of autonomous vehicles and intelligent infrastructure to consumer, business, government, public safety and community audiences. These efforts include Velodyne’s World Safety Summit on Autonomous Technology . The event has sparked collaborative work to advance solutions for rolling out autonomy and ADAS with the goal of improving safety on the roadways. Velodyne also partners with Mothers Against Drunk Driving (MADD) on public education about improving safety on roadways.
Velodyne’s lidar sensors are used in a rich ecosystem of customers and applications, which is highlighted in the Automated with Velodyne program. Partners in the program provide solutions for smart city, infrastructure, autonomous vehicles and more. Within the program, Velodyne is working to advance research in transportation infrastructure, partnering with University of Nevada, Reno . The university’s Nevada Center for Applied Research, working in conjunction with the Nevada DOT and Nevada Governor’s Office of Economic Development , is using Velodyne’s sensors in its Intelligent Mobility initiative. Velodyne is also partnering with automotive OEMs, and robotaxi and autonomous shuttle companies to enable safe and efficient transportation options for cities. For instance, Voyage has built the technology and services to bring autonomous transportation to those who need it, beginning in retirement communities.
“Lidar is a foundational technology that will help drive intelligent mobility in smart city applications and in vehicles on our roadways,” said Shailen Bhatt, President & CEO, ITS America. “Velodyne has demonstrated a strong commitment and great skills in advancing public knowledge about lidar and how autonomous technology can greatly improve transportation. We welcome their contributions in helping ITS America promote intelligent transportation technologies.”
“Velodyne Lidar is strongly aligned with the ITS America mission to improve mobility, advance safety on the roadways, and increase efficiency in our communities,” said Sally Frykman, VP of Communications, Velodyne Lidar. “We envision companies and government organizations will use Velodyne’s lidar sensors to enable a new generation of smart infrastructure through data collection and the deployment of autonomous vehicles.
About Velodyne Lidar
Velodyne provides smart, powerful lidar solutions for autonomy and driver assistance. Headquartered in San Jose, Calif., Velodyne is known worldwide for its portfolio of breakthrough lidar sensor technologies. Velodyne’s founder, David Hall, invented real-time surround view lidar systems in 2005 as part of Velodyne Acoustics. Mr. Hall’s invention revolutionized perception and autonomy for automotive, new mobility, mapping, robotics, and security. Velodyne’s high-performance product line includes a broad range of sensing solutions, including the cost-effective Puck™, the versatile Ultra Puck™, the autonomy-advancing Alpha Prime™, the ADAS-optimized VELARRAY™, and the groundbreaking software for driver assistance, Vella™.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200828005057/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SLB to Host 2026 Digital Investor Day10.6.2026 14:30:00 CEST | Press release
SLB (NYSE: SLB) will host an Investor Day on Wednesday, June 17, 2026, in New York, where leadership will outline their vision for SLB’s Digital business as digital technologies and AI continue to reshape the energy industry. The presentation will highlight SLB’s integrated digital strategy and portfolio, scalable growth opportunities powered by AI, and financial profile and outlook. Olivier Le Peuch, chief executive officer, SLB, will present at 9:00 a.m. U.S. Eastern Time (ET), and will discuss SLB’s digital strategy and business outlook. Stephane Biguet, chief financial officer, SLB, will present at approximately 11:00 a.m. ET, and will discuss the financial profile of SLB’s Digital business, the market opportunity and SLB’s 2030 digital ambitions. Mr. Le Peuch and Mr. Biguet will be joined by divisional leadership, who will provide further insight into Digital’s competitive differentiation supported by its mission-critical platform, driving transformation for customers. A live webc
Wolters Kluwer expands its Libra AI workspace with authoritative Swiss legal content from leading publisher Stämpfli10.6.2026 14:00:00 CEST | Press release
Collaboration brings trusted Swiss legal expertise directly into AI‑supported legal research, drafting and review Wolters Kluwer Legal & Regulatory today announced the expansion of Libra by Wolters Kluwer, its AI-powered legal workspace, to include professional legal content from Stämpfli Publishers, one of Switzerland’s most respected legal publishers. As a result, Swiss legal professionals using Libra by Wolters Kluwer gain direct access to the legal literature that shapes their daily work – fully integrated into a single AI-supported workflow. The content offering includes commentaries, practitioner guides, yearbooks and selected journals from Stämpfli Publishers – including the renowned “Berner Kommentar”, and the company’s succinct commentaries and legal textbooks. In addition, primary sources of Swiss law at both federal and cantonal level are integrated into the workspace. The offering will be continuously expanded over time, with additional titles gradually integrated into the
Macrobond Launches AI Data Feed with MCP and Skill, Bringing Governed Macroeconomic Intelligence to Enterprise AI Workflows10.6.2026 14:00:00 CEST | Press release
Two new delivery components, MCP for conversational AI and Skill for programmatic access, enable institutions to retrieve trusted, licensed macroeconomic data directly within their AI environments. Macrobond today announced the general availability of the Macrobond AI Data Feed Service, a purpose-built product, enabling financial institutions to integrate governed macroeconomic intelligence directly into AI-powered research, investment, and strategy workflows. Available now with MCP, Skill and API delivery components, the AI Data Feed helps organizations accelerate macroeconomic research and insight generation and reduce reliance on fragmented or ungoverned data sources. By delivering reliable, licensed, economic data integrated directly within AI chat interfaces and coding environments, the AI Data Feed Service provides a trusted foundation for enterprise AI initiatives. As generative AI becomes embedded in research, investment, and strategy workflows, face a foundational challenge: m
Parse Biosciences Launches the Next Generation of its Immune Profiling Kits10.6.2026 14:00:00 CEST | Press release
Updated kits deliver improved sensitivity and receptor recovery for single cell immune repertoire profiling at unprecedented scale Parse Biosciences, the leading provider of scalable and accessible single cell sequencing solutions, today launched the next generation of its Evercode™ TCR and Evercode™ BCR kits, shipping to customers worldwide. The updated kits deliver a streamlined workflow, better whole transcriptome sequencing library efficiency, and improved performance, enabling researchers to resolve rare clonotypes and profile immune responses at unprecedented scale. Immunology researchers are working to understand complex adaptive immune responses, but meaningful signals are often rare, transient, or difficult to capture across large, sample-limited studies. Parse's immune profiling portfolio combines scale, sensitivity, and fixation-first workflows with paired TCR or BCR and whole transcriptome profiling, helping researchers connect clonal identity to cell state across high-thro
GENESIS Pharma Expands Strategic Commercial Partnership with Alnylam Pharmaceuticals for RNAi Therapeutics to the Nordic Region10.6.2026 13:47:00 CEST | Press release
The expanded partnership adds Denmark, Finland, Norway and Sweden to GENESIS Pharma’s existing network of thirteen Southeast European markets.It grants rights for the commercialization of Alnylam’s RNAi therapeutics for serious cardiomyopathy conditions and rare genetic diseases. GENESIS Pharma, a leading regional biopharma company focused on the commercialization of innovative medicines in Europe, today announced the expansion of its longstanding commercial partnership with Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), the leading RNAi therapeutics company. The extended agreement broadens the geographical reach of the collaboration to include four Nordic markets -Denmark, Finland, Norway, and Sweden- alongside the thirteen markets in Southeast Europe already within the scope of the partnership. GENESIS Pharma shall commercialize a portfolio of RNAi therapeutics for serious cardiomyopathy conditions and rare genetic diseases across this expanded territory. The partnership, established
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
